Cellular Immunotherapy Synergize Chemotherapy in Patients With Stage IV NSCLC
Status:
Unknown status
Trial end date:
2019-01-01
Target enrollment:
Participant gender:
Summary
This is a randomized, open-label, phaseâ…¡ study evaluating efficacy and safety of DC
(dendritic cells) vaccine concurrent with chemotherapy compared to chemotherapy alone in
patients with stage IV NSCLC (non small cell lung cancer) with wild-type EGFR (epidermal
growth factor receptor).